Boston Scientific (BSX) Accumulated Expenses (2009 - 2026)

Boston Scientific's Accumulated Expenses history runs 18 years deep, the most recent figure standing at $2.5 billion for Q1 2026.

• In Q1 2026, Accumulated Expenses rose 6.8% year-over-year to $2.5 billion; the TTM figure through Mar 2026 stood at $2.5 billion (up 6.8% YoY), while the FY2025 annual figure was $3.2 billion, up 15.43% from the prior year.
• Accumulated Expenses came in at $2.5 billion for Q1 2026 at Boston Scientific, down from $3.2 billion in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $3.2 billion in Q4 2025 to a low of $1.9 billion in Q1 2023.
• A 5-year average of $2.4 billion and a median of $2.3 billion in 2024 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses fell 18.36% in 2022 and advanced 22.5% in 2023, its largest moves.
• Boston Scientific's Accumulated Expenses stood at $2.2 billion in 2022, then grew by 22.5% to $2.6 billion in 2023, then grew by 4.8% to $2.8 billion in 2024, then grew by 15.43% to $3.2 billion in 2025, then dropped by 21.46% to $2.5 billion in 2026.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $2.5 billion, $3.2 billion, and $3.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison